Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Clarification sought from Dr Reddys Laboratories
Date: 01-09-2017The Exchange has sought clarification from Dr Reddys Laboratories on September 01, 2017 with reference to news flashed on http://www.thehindubusinessline.com dated September 01, 2017 quoting ‘Dr Reddys settles patent row with Vivus’.
The above information is a part of company’s filings submitted to BSE.